JP2017057207A5 - - Google Patents

Download PDF

Info

Publication number
JP2017057207A5
JP2017057207A5 JP2016224622A JP2016224622A JP2017057207A5 JP 2017057207 A5 JP2017057207 A5 JP 2017057207A5 JP 2016224622 A JP2016224622 A JP 2016224622A JP 2016224622 A JP2016224622 A JP 2016224622A JP 2017057207 A5 JP2017057207 A5 JP 2017057207A5
Authority
JP
Japan
Prior art keywords
substituted
alkyl
alkylaminoalkyl
general formula
following general
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016224622A
Other languages
English (en)
Japanese (ja)
Other versions
JP6242464B2 (ja
JP2017057207A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017057207A publication Critical patent/JP2017057207A/ja
Publication of JP2017057207A5 publication Critical patent/JP2017057207A5/ja
Application granted granted Critical
Publication of JP6242464B2 publication Critical patent/JP6242464B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016224622A 2012-04-27 2016-11-18 トランス−2−デセン酸誘導体及びこれを含有する医薬 Expired - Fee Related JP6242464B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012103306 2012-04-27
JP2012103306 2012-04-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2014512706A Division JP6047152B2 (ja) 2012-04-27 2013-04-26 トランス−2−デセン酸誘導体及びこれを含有する医薬

Publications (3)

Publication Number Publication Date
JP2017057207A JP2017057207A (ja) 2017-03-23
JP2017057207A5 true JP2017057207A5 (cg-RX-API-DMAC10.html) 2017-04-27
JP6242464B2 JP6242464B2 (ja) 2017-12-06

Family

ID=49483290

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014512706A Expired - Fee Related JP6047152B2 (ja) 2012-04-27 2013-04-26 トランス−2−デセン酸誘導体及びこれを含有する医薬
JP2016224622A Expired - Fee Related JP6242464B2 (ja) 2012-04-27 2016-11-18 トランス−2−デセン酸誘導体及びこれを含有する医薬

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2014512706A Expired - Fee Related JP6047152B2 (ja) 2012-04-27 2013-04-26 トランス−2−デセン酸誘導体及びこれを含有する医薬

Country Status (14)

Country Link
US (1) US9428477B2 (cg-RX-API-DMAC10.html)
EP (1) EP2842942B1 (cg-RX-API-DMAC10.html)
JP (2) JP6047152B2 (cg-RX-API-DMAC10.html)
KR (1) KR20150013143A (cg-RX-API-DMAC10.html)
CN (1) CN104254521B (cg-RX-API-DMAC10.html)
AU (1) AU2013253408C1 (cg-RX-API-DMAC10.html)
BR (1) BR112014026535A2 (cg-RX-API-DMAC10.html)
CA (1) CA2870822C (cg-RX-API-DMAC10.html)
ES (1) ES2618297T3 (cg-RX-API-DMAC10.html)
IL (1) IL235267A (cg-RX-API-DMAC10.html)
RU (1) RU2602810C2 (cg-RX-API-DMAC10.html)
SG (1) SG11201406942SA (cg-RX-API-DMAC10.html)
TW (1) TWI636975B (cg-RX-API-DMAC10.html)
WO (1) WO2013161993A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6086890B2 (ja) * 2013-10-25 2017-03-01 日本臓器製薬株式会社 トランス−2−デセン酸誘導体を含有する医薬
KR102496390B1 (ko) * 2014-06-06 2023-02-03 디킨 유니버시티 신경발달 질환 및 장애의 치료 방법
CA3079819C (en) * 2017-11-06 2023-03-14 Acelot, Inc. Small molecule drugs and related methods for treatment of diseases related to a.beta.42 oligomer formation
CN118976017A (zh) * 2024-08-02 2024-11-19 南京邮电大学 中碳链烯酸及其衍生物在制备促进血管再生和神经功能恢复药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3294794A (en) * 1963-12-19 1966-12-27 Raiford L Holmes 4-(2-alkenoyl, or 2 bromoalkanoyl) morpholines
GB2321455A (en) 1997-01-24 1998-07-29 Norsk Hydro As Lipophilic derivatives of biologically active compounds
US7109364B2 (en) * 2000-02-07 2006-09-19 Zhenhua Yang Group of anti-cancer compounds with specific structure and their production method
US7329767B2 (en) * 2003-10-03 2008-02-12 International Flavors & Fragrances Inc. Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof
WO2009038110A1 (ja) 2007-09-19 2009-03-26 Nagoya Industrial Science Research Institute 神経栄養因子様作用剤
US9414590B2 (en) * 2009-03-16 2016-08-16 Marrone Bio Innovations, Inc. Chemical and biological agents for the control of molluscs
RU2549697C2 (ru) * 2009-04-20 2015-04-27 Марроун Био Инновэйшнс, Инк. Композиция и способ для контроля численности моллюсков
EP2710892B1 (en) * 2009-07-21 2016-12-14 Marrone Bio Innovations, Inc. Use of sarmentine and its analogs for controlling weeds
SG10201503402XA (en) * 2010-01-27 2015-06-29 Takeda Pharmaceutical Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent
ES2624845T3 (es) * 2010-09-29 2017-07-17 Intervet International B.V. Compuestos de N-heteroarilo con unidad de puente cíclico para el tratamiento de enfermedades parasitarias
JP5044059B2 (ja) 2010-11-02 2012-10-10 公益財団法人名古屋産業科学研究所 トランス−2−デセン酸誘導体及びこれを含有する医薬

Similar Documents

Publication Publication Date Title
PH12018500264A1 (en) 2-(het)aryl-substituted condensed heterocyclic derivatives as pest control agents
MX2015010837A (es) Compuestos de antranilamida, sus mezclas y el uso de los mismos como pesticidas.
CY1118319T1 (el) Αλατα και πολυμορφα της 8-φθορο-2-{4-[(μεθυλαμινο)μεθυλο]φαινυλο}-1,3,4,5-τετραϋδρο-6η-αζεπινο[5,4,3-cd]ινδολο-6-ονης
AR105292A1 (es) Fenoxihalogenofenilamidinas y su uso como fungicidas
AR092790A1 (es) Derivados bencimidazolicos del acido hidroxamico
PE20141191A1 (es) Compuestos como inhibidores de bace
PE20171057A1 (es) Derivados espirodiamina como inhibidores de la aldosterona sintasa
IL260153B (en) Process for the preparation of 4-phenyl-5-alkoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]-3-oxo-5,6,8,8a-tetrahydro-1h-imidazo[1,5-a]pyrazin-2-yl]-carboxylic acid
ES2723277T3 (es) Una forma sólida de clorhidrato de (S)-3-(4-((4-morfolinometil)bencil)oxi)-1-oxoisoindolin-2-il)piperidina-2,6-diona
MX387483B (es) Preparación farmacéutica.
MX373700B (es) Composicion acuosa novedosa.
SMT201700142T1 (it) SALE DI CAMSILATO DI (1r, 1’R, 4R)-4-METOSSI-5’’-METIL-6’-[5-(PROP-1-IN-1-IL)PIRIDIN-3-IL]-3’H-DISPIRO[CICLOESANO-1,2’-INDEN-1’2’-IMIDAZOLO]-4’’-AMMINA E SUE FORME CRISTALLINE PER IL TRATTAMENTO DI PATOLOGIE A[BETA]-CORRELATE COME PER ESEMPIO LA MALATTIA DI ALZHEIMER
JP2015199738A5 (cg-RX-API-DMAC10.html)
WO2014192030A3 (en) An improved process for preparation of dabigatran etexilate and pharmaceutically acceptable acid addition salts thereof
WO2015068175A3 (en) An improved process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof
WO2016135747A3 (en) Process for the preparation of amorphous (1s)-1,5-anhvdro-1-[3-[[5-(4 fluorophennyl)-2-thienyl]methvl]-4-methylphenyl]-d-glucitol and its polymorphs thereof
MX2017007572A (es) Composicion acuosa.
EA201792422A1 (ru) Способ получения 2-{4-[2-({[2-(4-хлорфенил)-1,3-тиазол-4-ил]метил}сульфанил)-3,5-дициан-6-(пирролидин-1-ил)пиридин-4-ил]фенокси}этил-l-аланил-l-аланинат моногидрохлорида
WO2016142819A3 (en) Novel process for the preparation of ranolazine
IL264780B (en) A method for producing 2-(3,6-dihalopyridin-2-yl)-3h-imidazolo[4,5-c]pyridine derivatives and similar compounds by reacting a 3h-imidazolo[4,5-c]pyridine derivative with a base Organometallic zinc-amine
MX2016012485A (es) Proceso para preparar 3-(3-(4-(1-aminociclobutil)fenil)-5-fenil-3h -imidazo[4,5-b]piridin-2-il)piridin-2-amina.
WO2014049612A3 (en) Processes and polymorphs of 5-[4-[4-(5-cyano-1h-indol-3-yl) butyl]-1-piperazinyl]-2-benzofuran carboxamide and its salts
MX366985B (es) Sales derivadas de bencisoxazol.
WO2015196113A3 (en) Anhydrous crystalline free base form of-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-3-ethoxy-1,2-benzisoxazole
JP2017019744A5 (cg-RX-API-DMAC10.html)